A monoclonal rat anti-mouse EMAP II antibody that functionally neutralizes pro- and mature-EMAP II in vitro

Journal of Immunological Methods

Volumn 350, Issue 1-2, 2009, Pages 22-28

  Rajashekhar, Gangaraju ^a   Mitnacht Kraus, Rita ^b   Ispe, Ute ^b   Garrison, Jana ^a   Hou, Yonghao ^a   Taylor, Brian ^a   Petrache, Irina ^a   Vestweber, Dietmar ^b   Clauss, Matthias ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Apoptosis; CXCR3; Endothelial; Hybridoma; Inflammation; Monocyte migration; Neutralizing monoclonal antibodies

Indexed keywords

ANTIBODY; ENDOTHELIAL MONOCYTE ACTIVATING POLYPEPTIDE II; ENDOTHELIAL MONOCYTE ACTIVATING POLYPEPTIDE II MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY M7 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYBRIDOMA; IN VITRO STUDY; MONOCYTE; MOUSE; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CYTOKINES; ENDOTHELIUM, VASCULAR; HUMANS; MICE; MONOCYTES; NEOPLASM PROTEINS; PROTEIN PRECURSORS; RATS; RATS, INBRED LEW; RNA-BINDING PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MURINAE; RATTUS;

EID: 70349828998     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2009.08.003     Document Type: Article

References (28)

1. Awasthi N., Schwarz M.A., Verma V., Cappiello C., and Schwarz R.E. Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling. Lab. Invest. 89 (2009) 38
2. Barnett G., Jakobsen A.M., Tas M., Rice K., Carmichael J., and Murray J.C. Prostate adenocarcinoma cells release the novel proinflammatory polypeptide EMAP-II in response to stress. Cancer Res. 60 (2000) 2850
3. Behrensdorf H.A., van de Craen M., Knies U.E., Vandenabeele P., and Clauss M. The endothelial monocyte-activating polypeptide II (EMAP II) is a substrate for caspase-7. FEBS Lett. 466 (2000) 143
4. Berger A.C., Alexander H.R., Tang G., Wu P.S., Hewitt S.M., Turner E., Kruger E., Figg W.D., Grove A., Kohn E., Stern D., and Libutti S.K. Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis. Microvasc. Res. 60 (2000) 70
5. Castro C.M., Yang Y., Zhang Z., and Linnoila R.I. Attenuation of pulmonary neuroendocrine differentiation in mice lacking Clara cell secretory protein. Lab. Invest. 80 (2000) 1533
6. Clauss M. Molecular biology of the VEGF and the VEGF receptor family. Semin. Thromb. Hemost. 26 (2000) 561
7. Hou Y., Plett P.A., Ingram D.A., Rajashekhar G., Orschell C.M., Yoder M.C., March K.L., and Clauss M. Endothelial-monocyte-activating polypeptide II induces migration of endothelial progenitor cells via the chemokine receptor CXCR3. Exp. Hematol. 34 (2006) 1125
8. Journeay W.S., Janardhan K.S., and Singh B. Expression and function of endothelial monocyte-activating polypeptide-II in acute lung inflammation. Inflamm. Res. 56 (2007) 175
9. Kao J., Ryan J., Brett G., Chen J., Shen H., Fan Y.G., Godman G., Familletti P.C., Wang F., Pan Y.C., et al. Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms. J. Biol. Chem. 267 (1992) 20239
10. Kao J., Houck K., Fan Y., Haehnel I., Libutti S.K., Kayton M.L., Grikscheit T., Chabot J., Nowygrod R., Greenberg S., Kuang W.-J., Leung D.W., Hayward J.R., Kisiel W., Heath M., Brett J., and Stern D.M. Characterization of a novel tumor-derived cytokine. Endothelial- monocyte activating polypeptide II. J. Biol. Chem. 269 (1994) 25106
11. Keezer S.M., Ivie S.E., Krutzsch H.C., Tandle A., Libutti S.K., and Roberts D.D. Angiogenesis inhibitors target the endothelial cell cytoskeleton through altered regulation of heat shock protein 27 and cofilin. Cancer Res. 63 (2003) 6405
12. Kim E., Kim S.H., Kim S., and Kim T.S. The novel cytokine p43 induces IL-12 production in macrophages via NF-kappaB activation, leading to enhanced IFN-gamma production in CD4+ T cells. J. Immunol. 176 (2006) 256
13. Knies U.E., Behrensdorf H.A., Mitchell C.A., Deutsch U., Risau W., Drexler H.C., and Clauss M. Regulation of endothelial monocyte-activating polypeptide II release by apoptosis. Proc Natl Acad Sci U S A 95 (1998) 12322
14. Knies U.E., Kroger S., and Clauss M. Expression of EMAP II in the developing and adult mouse. Apoptosis 5 (2000) 141
15. Ko Y.G., Park H., Kim T., Lee J.W., Park S.G., Seol W., Kim J.E., Lee W.H., Kim S.H., Park J.E., and Kim S. A cofactor of tRNA synthetase, p43, is secreted to up-regulate proinflammatory genes. J. Biol. Chem. 276 (2001) 23028
16. Liu J., and Schwarz M.A. Identification of protease-sensitive sites in Human Endothelial-Monocyte Activating Polypeptide II protein. Exp. Cell Res. 312 12 (2006) 2231-2237
17. Loetscher P., Seitz M., Clark Lewis I., Baggiolini M., and Moser B. Monocyte chemotactic proteins MCP-1, MCP-2, and MCP-3 are major attractants for human CD4+ and CD8+ T lymphocytes. Faseb J 8 (1994) 1055
18. Matschurat S., Knies U.E., Person V., Fink L., Stoelcker B., Ebenebe C., Behrensdorf H.A., Schaper J., and Clauss M. Regulation of EMAP II by Hypoxia. Am. J. Pathol. 162 (2003) 93
19. Park S.G., Kang Y.S., Kim J.Y., Lee C.S., Ko Y.G., Lee W.J., Lee K.U., Yeom Y.I., and Kim S. Hormonal activity of AIMP1/p43 for glucose homeostasis. Proc Natl Acad Sci U S A 103 (2006) 14913
20. Petrache I., Natarajan V., Zhen L., Medler T.R., Richter A.T., Cho C., Hubbard W.C., Berdyshev E.V., and Tuder R.M. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat. Med. 11 (2005) 491
21. Quevillon S., Agou F., Robinson J.C., and Mirande M. The p43 component of the mammalian multi-synthetase complex is likely to be the precursor of the endothelial monocyte-activating polypeptide II cytokine. J. Biol. Chem. 272 (1997) 32573
22. Romagnani P., Annunziato F., Lasagni L., Lazzeri E., Beltrame C., Francalanci M., Uguccioni M., Galli G., Cosmi L., Maurenzig L., Baggiolini M., Maggi E., Romagnani S., and Serio M. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J. Clin. Invest. 107 (2001) 53
23. Romagnani P., Lasagni L., Annunziato F., Serio M., and Romagnani S. CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol. 25 (2004) 201
24. Schwarz M.A., Kandel J., Brett J., Li J., Hayward J., Schwarz R.E., Chappey O., Wautier J.L., Chabot J., Lo Gerfo P., and Stern D. Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells. J. Exp. Med. 190 (1999) 341
25. Shalak V., Kaminska M., Mitnacht-Kraus R., Vandenabeele P., Clauss M., and Mirande M. The EMAPII cytokine is released from the mammalian multisynthetase complex after cleavage of its p43/proEMAPII component. J. Biol. Chem. 276 (2001) 23769
26. Wakasugi K., and Schimmel P. Highly differentiated motifs responsible for two cytokine activities of a split human tRNA synthetase. J. Biol. Chem. 274 (1999) 23155
27. Wakasugi K., and Schimmel P. Two distinct cytokines released from a human aminoacyl-tRNA synthetase. Science 284 (1999) 147
28. Zhang F.R., and Schwarz M.A. Pro-EMAP II is not primarily cleaved by caspase-3 and -7. Am. J. Physiol. Lung Cell Mol. Physiol. 282 (2002) L1239